Gary J. Nabel, M.D., Ph.D.

Gary J. Nabel, M.D., Ph.D.

DirectoratCandel Therapeutics· In proxies 2023–2025

Gary J. Nabel, M.D., Ph.D. sits on 2 public boards.

Boards1

  • Candel TherapeuticsDirector · 3 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Candel TherapeuticsPublic company · 2 yr
    • Director2024 – Present · 2 yrStock in role +661%
  2. Opko HealthPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Siga Technologies, Inc.Public company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?